Therapy Areas: Cardiovascular
DiNAQOR names new executive vice president, Medical Devices
24 September 2021 -

DiNAQOR, a Swiss-based genetic medicine platform company, announced on Thursday that it has named Mark Dehdashtian as its new executive vice president, Medical Devices.

In the new role, Dehdashtian will manage the company's newly established medical device division including its new manufacturing facility based in Laguna Hills, California and will be responsible for the design, development, and production of genetic medicine delivery devices for the firm's localised, catheter-based multi-organ access platform.

Dehdashtian has served Edwards Lifesciences for 25-year where he held various senior-level positions, including vice president of Research and Development for the Heart Valve Therapy, Advanced Technology and Cardiac Surgery Systems divisions. He was instrumental in commercialising the transcatheter heart valve transapical systems and holds over 60 United States patents and many international patents. He has served as a member of the medical technology steering committees to develop industry-wide standards.



Related Headlines